https://lungdaily.org/news/2026-11-13-ronald-g-crystal-honoured-with-the-weill-award/LungDailyen2026-11-13T20:00:20+00:00Ronald G. Crystal: honoured with the Weill Awardhttps://lungdaily.org/news/2026-11-13-fda-feedback-supports-planned-trial-and-possible-early-approval-for-bl/LungDailyen2026-11-13T17:00:17+00:00FDA feedback supports planned trial and possible early approval for Black Diamond lung cancer drughttps://lungdaily.org/news/2026-11-13-ers-opens-online-registration-for-european-parliament-respiratory-heal/LungDailyen2026-11-13T16:30:16+00:00ERS opens online registration for European Parliament respiratory health policy discussionhttps://lungdaily.org/news/2026-11-13-study-pairs-machine-learning-with-explainability-to-examine-early-pred/LungDailyen2026-11-13T15:45:18+00:00Study pairs machine learning with explainability to examine early predictors of persistent childhood asthmahttps://lungdaily.org/news/2026-11-13-lung-cancer-detection-rates-in-general-population-screening-registry-c/LungDailyen2026-11-13T15:30:18+00:00Lung cancer detection rates in general-population screening registry comparable to NLST, study findshttps://lungdaily.org/news/2026-11-13-mtap-loss-found-in-17-of-nsclc-by-ihc-more-often-in-driver-positive-st/LungDailyen2026-11-13T15:00:16+00:00MTAP loss found in 17% of NSCLC by IHC, more often in driver-positive stage IV diseasehttps://lungdaily.org/news/2026-11-13-merck-receives-positive-chmp-opinion-to-extend-enflonsia-use-to-childr/LungDailyen2026-11-13T14:30:15+00:00Merck receives positive CHMP opinion to extend Enflonsia use to children up to 24 monthshttps://lungdaily.org/news/2026-11-13-dr-alexey-kulikov-pneumonia-prevention-is-part-of-everyday-ncd-care/LungDailyen2026-11-13T14:00:15+00:00Dr Alexey Kulikov: Pneumonia prevention is part of everyday NCD carehttps://lungdaily.org/news/2026-11-13-il-33-blockade-cut-copd-exacerbations-by-29-34-in-two-phase-iii-trials/LungDailyen2026-11-13T13:00:15+00:00IL-33 blockade cut COPD exacerbations by 29-34% in two Phase III trials, EMJ reportshttps://lungdaily.org/news/2026-11-13-blossomhill-gets-fda-alignment-on-phase-2-dose-for-lung-cancer-drug-2/LungDailyen2026-11-13T10:45:12+00:00BlossomHill gets FDA alignment on phase 2 dose for lung cancer drughttps://lungdaily.org/news/2026-11-13-who-370-000-people-developed-drug-resistant-tb-in-2025/LungDailyen2026-11-13T10:30:24+00:00WHO: 370,000 people developed drug-resistant TB in 2025https://lungdaily.org/news/2026-11-13-charles-swanton-receives-bob-pinedo-award-for-lifetime-contribution-to/LungDailyen2026-11-13T10:00:27+00:00Charles Swanton receives Bob Pinedo award for lifetime contribution to lung cancer researchhttps://lungdaily.org/news/2026-11-13-who-tb-incidence-down-14-since-2015-far-short-of-50-milestone-for-2025/LungDailyen2026-11-13T09:30:14+00:00WHO: TB incidence down 14% since 2015, far short of 50% milestone for 2025https://lungdaily.org/news/2026-11-13-dr-chacon-lozsan-f-oxygen-saturation-can-look-normal-despite-rising-co/LungDailyen2026-11-13T09:00:18+00:00Dr. Chacón-Lozsán F.: Oxygen saturation can look normal despite rising CO₂ in hypercapnic failurehttps://lungdaily.org/news/2026-11-13-chest-research-letter-examines-geographic-reach-and-eligibility-criter/LungDailyen2026-11-13T08:00:26+00:00CHEST Research Letter examines geographic reach and eligibility criteria in COPD trialshttps://lungdaily.org/news/2026-11-13-higher-sama-use-linked-to-greater-cardiovascular-and-mortality-risks-i/LungDailyen2026-11-13T06:00:18+00:00Higher SAMA use linked to greater cardiovascular and mortality risks in asthma and COPDhttps://lungdaily.org/news/2026-11-12-meeting-who-air-quality-guidelines-could-avert-9-4-million-deaths-a-ye/LungDailyen2026-11-12T21:20:01+00:00Meeting WHO air quality guidelines could avert 9.4 million deaths a year in LMICs, study suggestshttps://lungdaily.org/news/2026-11-12-who-an-estimated-10-6-million-people-developed-tb-in-2025/LungDailyen2026-11-12T20:00:15+00:00WHO: an estimated 10.6 million people developed TB in 2025https://lungdaily.org/news/2026-11-12-ethris-announces-positive-phase-2a-results-for-eth47-in-mild-to-modera/LungDailyen2026-11-12T15:45:18+00:00Ethris announces positive Phase 2a results for ETH47 in mild-to-moderate asthmahttps://lungdaily.org/news/2026-11-12-meta-analysis-links-copd-to-roughly-doubled-odds-of-postoperative-deli/LungDailyen2026-11-12T15:30:25+00:00Meta-analysis links COPD to roughly doubled odds of postoperative deliriumhttps://lungdaily.org/news/2026-11-12-baseline-tp53-mutation-and-pd-l1-linked-to-early-progression-on-first/LungDailyen2026-11-12T15:00:15+00:00Baseline TP53 mutation and PD-L1 linked to early progression on first-line osimertinib in EGFR-mutant NSCLChttps://lungdaily.org/news/2026-11-12-gps-to-receive-40m-to-support-patients-with-frailty-heart-disease-and/LungDailyen2026-11-12T14:30:15+00:00GPs to receive £40m to support patients with frailty, heart disease and COPD this winterhttps://lungdaily.org/news/2026-11-12-moderna-rsv-vaccine-shown-to-give-strong-protection-against-serious-ca/LungDailyen2026-11-12T14:00:16+00:00Moderna RSV vaccine shown to give strong protection against serious cases in adults 50 and olderhttps://lungdaily.org/news/2026-11-12-lung-health-check-ireland-80-of-pilot-diagnoses-are-at-early-stage/LungDailyen2026-11-12T13:00:14+00:00Lung Health Check Ireland: 80% of pilot diagnoses are at early stagehttps://lungdaily.org/news/2026-11-12-canakinumab-reduces-nodule-size-in-high-risk-lung-precancers-onclive-r/LungDailyen2026-11-12T10:45:15+00:00Canakinumab reduces nodule size in high-risk lung precancers, OncLive reportshttps://lungdaily.org/news/2026-11-12-feno-outperforms-blood-eosinophils-for-diagnosing-suspected-asthma-stu/LungDailyen2026-11-12T10:30:13+00:00FeNO outperforms blood eosinophils for diagnosing suspected asthma, study reportshttps://lungdaily.org/news/2026-11-12-89-of-124-surveyed-patients-say-doctors-did-not-mention-low-dose-ct-lu/LungDailyen2026-11-12T10:01:44+00:0089% of 124 surveyed patients say doctors did not mention low-dose CT lung cancer screeninghttps://lungdaily.org/news/2026-11-12-trop2-normalized-membrane-ratio-proposed-as-predictor-for-dato-dxd-in/LungDailyen2026-11-12T09:30:13+00:00TROP2 normalized membrane ratio proposed as predictor for Dato-DXd in NSCLChttps://lungdaily.org/news/2026-11-12-amicus-tells-supreme-court-lungs-of-even-children-in-delhi-are-not-pin/LungDailyen2026-11-12T09:00:15+00:00Amicus tells Supreme Court lungs of even children in Delhi are 'not pink'https://lungdaily.org/news/2026-11-12-cardiopulmonary-events-were-more-common-in-the-three-years-before-copd/LungDailyen2026-11-12T08:00:14+00:00Cardiopulmonary events were more common in the three years before COPD diagnosis, study findshttps://lungdaily.org/news/2026-11-12-investigational-immunotherapy-nearly-doubled-overall-survival-in-advan/LungDailyen2026-11-12T06:00:13+00:00Investigational immunotherapy nearly doubled overall survival in advanced squamous NSCLC, ASCO Post reportshttps://lungdaily.org/news/2026-11-11-rome-criteria-reclassify-most-hospitalised-copd-exacerbations-report-s/LungDailyen2026-11-11T22:39:22+00:00Rome criteria reclassify most hospitalised COPD exacerbations, report says